Reiter's syndrome and reactive arthritis: A current view

Seminars in Arthritis and Rheumatism

Volumn 24, Issue 3, 1994, Pages 190-210

  Hughes, Rodney A ^a   Keat, Andrew C ^a  

^a NONE

Author keywords

bacteria; pathogenesis; reactive arthritis; Reiter's syndrome

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; BACTERIAL DNA; BACTERIAL RNA; BACTERIUM LIPOPOLYSACCHARIDE; DOXYCYCLINE; HLA B27 ANTIGEN; OXYTETRACYCLINE; TETRACYCLINE;

ANTIBIOTIC THERAPY; ANTIGEN PRESENTING CELL; BACTERIAL ARTHRITIS; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; DISEASE PREDISPOSITION; HUMAN; IMMUNOPATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REITER SYNDROME; REVIEW; SALMONELLA ENTERITIDIS; SEXUAL TRANSMISSION; SHIGELLA FLEXNERI;

ANTIGENS, BACTERIAL; ARTHRITIS, REACTIVE; DNA, BACTERIAL; HUMAN; JOINTS; REITER DISEASE; RNA, BACTERIAL;

EID: 0028577952     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-0172(94)90075-2     Document Type: Article

References (261)

1. Reiter's syndrome and reactive arthritis in perspective
2. A syndrome of unknown etiology characterised by urethritis, conjunctivitis, and arthritis (so-called Reiter's disease)
3. Reiter's disease and HL-A 27
4. Causes of arthritis
5. Arthritis associated with Yersinia enterocolitica infection
6. HL-A 27 in Reactive Arthritis. A study of Yersinia arthritis and Reiter's disease
7. Arthritis and Intestinal Infection
8. Relationships between genitourinary infection and complicating arthritis
9. Chlamydial infection in the aetiology of arthritis
10. Reiter's disease: a study of 344 cases observed in Finland
11. Arthritis associated with Salmonella infections
12. Clinical picture of reactive Salmonella arthritis
13. Arthritis due to Salmonella typhimurium Report of 12 cases of migratory arthritis in association with Salmonella typhimurium infection
14. Yersinia pseudotuberculosis and arthritis
15. Reiter's syndrome associated with Campylobacter fetus infection
16. Reactive arthritis associated with Campylobacter infection of the bowel
17. Post-Gonorrhoeal Arthritis is Reiter's syndrome
18. Aseptic arthritis after gonorrhoea
19. Syndrome de Fiessinger Leroy Reiter chez l'enfant et Ureaplasma Urealyticum. (Mycoplasma Tiny)
20. A seronegative arthropathy and Escherichia coli diarrhoea
21. Reactive arthritis associated with Cryptosporidium enteritis
22. Syndrome de Fiessinger Leroy avec polyneurite
23. Reactive arthritis due to infestation with Giardia lamblia
24. Reactive arthritis associated with Clostridium difficile
25. Reactive arthritis associated with Shigella sonnei infection
26. Arthritis associated with Strongyloides stercoralis
27. Reactive arthritis induced by parasitic infection
28. Lung abscess and reactive arthritis: rare complications of leptospirosis
29. Poststreptococcal reactive arthritis
30. The Lyme spirochaete: Another cause of Reiter's syndrome
31. Does reactive arthritis to tuberculosis (Poncets disease) exist?
32. Reactive arthritis from Blastocystis hominis
33. Psittacosis presenting with Reiter's syndrome
34. Reactive arthritis associated with Brucellosis: HAL studies
35. Pneumonia, myocarditis and reactive arthritis due to Chlamydia pneumoniae
36. Intra-articular chlamydial antigen and inflammatory arthritis
37. The clinical features and HLA associations of reactive arthritis associated with non-gonococcal urethritis
38. Lager Louts—LAGER Arthritis
39. Incomplete Reiter's syndrome: Discriminating features and HL-A W27 in diagnosis
40. Undifferentiated Arthritis and Spondylarthropathy as a Major Problem of Diagnosis and Classification
41. Reactive arthritis
42. Clinically silent infections in patients with oligoarthritis: Results of a prospective study
43. Evidence that Chlamydia trachomatis causes seronegative arthritis in women
44. Synovial lymphocyte response to chlamydial stimulation associated with intrasynovial chlamydial antigen in a patient with “rheumatoid arthritis.”
45. Lymphocytes from the site of disease in reactive arthritis indicate antigen-specific immunopathology
46. Synovial lymphocyte responses to microbial antigens differentiate the arthritis of enteric reactive arthritis from the arthritis of inflammatory bowel disease
47. The specificity of synovial mononuclear cell responses to microbiological antigens in Reiter's syndrome
48. Cell-mediated immune responses of synovial mononuclear cells to sexually-transmitted, enteric and mumps antigens in patients with Reiter's syndrome, Rheumatoid arthritis and Ankylosing Spondylitis
49. Detection of Chlamydia (bedsonia) in certain infections in man. I. Laboratory procedures: Comparison of yolk sac and cell culture for detection and isolation
50. Isolation of Trachoma agent in cell culture
51. Infection by TRIC agent and other members of the Bedsonia group; with a note on Reiter's disease
52. Isolation of bedsoniae from the joints of patients with Reiter's syndrome
53. Demonstration, by cultures, of agents of the genus Bedsonia in joint fluid in cases of Fiessinger-Leroy-Reiter rheumatism [Fre]
54. Isolation of Bedsoniae from human arthritis and abortion tissues
55. Seronegative polyarthritis. The Bedsonia (Chlamydia) group of agents and Reiter's disease. A progress report
56. Inclusion conjunctivitis and Reiter's syndrome in a married couple. Chlamydia infections in a series of both diseases
57. Reiter's Syndrome
58. Etiological role of Halprovia-microorganisms of PLT group in diseases of joints. I. Excretion of Halprovia arthritidis from joints of patients with rheumatoid monosynovitis and Reiter's syndrome [Rus]
59. Reiter's disease in children
60. Chlamydial isolations and serology in Reiter's syndrome
61. Isolation of TRIC agents from the human genital tract
62. Chlamydial infection. Results of tests for chlamydia in patients suffering from acute Reiter's disease, compared with results of tests of the genital tract and rectum in patients with ocular infection due to TRIC agent
63. Chlamydial isolates from Reiter's syndrome
64. Role of Chlamydia in the etiology of Reiter's disease [Scr]
65. Chlamydia trachomatis and reactive arthritis: the missing link
66. The Role of Pleuropneumonia-like Organisms in Genitourinary and Joint Diseases
67. Reiter's Syndrome
68. Cortisone acetate and terramycin in polyarthritis of rats
69. Pleuropneumonia-like organisms bei Morbus Reiter und verwandten syndromen
70. The isolation of pleuropneumonia-like organisms from two cases of polyarthritis
71. Mycoplasma organisms in synovial fluid from rheumatic joints
72. Microbiological studies of Reiter's disease
73. Isolation and characterisation of mycoplasmas from patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus and Reiters Syndrome
74. The Genital Mycoplasmas (first of two parts)
75. Role of genital Mycoplasmas in nongonococcal urethritis and prostatitis
76. Human intra-urethral inoculation of ureplasmas.
77. The association of Mycoplasma hominis with arthritis.
78. The cutaneous manifestations of Gonorrhoea
79. The isolation of a filterable agent pathogenic for mice from a case of Reiters Disease
80. Mycoplasmas and arthritis
81. Septic arthritis due to Mycoplasma hominis
82. Mycoplasma hominis septic arthritis
83. Ureaplasma urealyticum septic arthritis in hypogammaglobulinemia
84. Chlamydiae
85. Inclusions de type viral dans l'urethre de certains rhumatisants. Inclusions dans le liquide synovial?
86. Sur l'origine virale possible du syndrome oculo-urethro-synovial
87. Etude par microscopie electronique des inclusions des cellules synoviales dans un cas de syndrome oculo-urethro-synovial (Fiessinger-Leroy-Reiter)
88. Light and microscopic observations on the synovitis of Reiters Disease
89. Unusual synovial fluid findings in Reiter's syndrome
90. Intracytoplasmic inclusions of immunoglobulins in rheumatoid arthritis and other diseases
91. Arthritis presumably caused by Chlamydia in Reiter syndrome. Case report with electron microscopic studies
92. Improved Syva MicroTrak Chlamydia trachomatis direct test method
93. Detection of Chlamydia trachomatis in genital specimens by the MicroTrak direct specimen test
94. Chlamydia infection in Reiter's syndrome [Ger]
95. Reproducibility of synovial fluid analyses. A study among four laboratories
96. Light and electron microscopic studies on the synovial membrane in Reiter's syndrome. Immunocytochemical identification of chlamydial antigen in patients with early disease
97. Folic acid treatment in methotrexate-treated rheumatoid arthritis patients: comment on the article by Furst and Kremer
98. Chlamydia-induced arthritis. Immunofluorescent antibody studies of the synovial fluid from 4 patients [letter]
99. A prospective and retrospective study of Chlamydia trachomatis in affected tissues of patients with reactive arthritis using a specific monoclonal antibody
100. Do bacterial antigens persist in reactive arthritis?
101. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis
102. Yersinia enterocolitica in the synovial membrane of patients with Yersinia-induced arthritis
103. Bacterial antigens in synovial biopsy specimens in yersinia triggered reactive arthritis
104. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis
105. The geri-aims. Reliability and validity of the arthritis impact measurement scales adapted for elderly respondents
106. Bacterial lipopolysaccharide in synovial cells in shigella triggered reactive arthritis
107. A pilot study on Yersinioses in south-eastern Finland
108. Presence of circulating immune complexes in Reiter's syndrome and Ankylosing Spondylitis
109. Circulating yersinia specific immune complexes after acute yersiniosis: a follow up study of patients with and without reactive arthritis
110. Yersinia specific immune complexes in the synovial fluid of patients with yersinia triggered reactive arthritis
111. Comparison of serum and synovial fluid chlamydial antibody titres
112. Salmonella specific antibodies in serum and synovial fluid in patients with reactive arthritis
113. Reactive arthritis: the role of bacterial antigens in inflammatory arthritis
114. Association of experimental chronic arthritis with persistence of group A streptococcal cell walls in the articular tissue
115. Bacterial lipopolysaccharide in reactive arthritis
116. The immunobiology of Chlamydia
117. Yersinia in intestinal biopsy specimens from patients with seronegative spondyloarthropathy: correlation with specific serum IgA antibodies
118. Association of persisting IgA response with yersinia triggered reactive arthritis: a study on 104 patients
119. Analysis of IgA antibodies to lipopolysaccharide in Yersinia-triggered reactive arthritis
120. Immunoblot analysis of IgM, IgG, and IgA responses to plasmid encoded released proteins of Yersinia enterocolitica in patients with or without yersinia triggered reactive arthritis
121. Specific DNA amplification
122. The polymerase chain reaction
123. Chlamydial DNA is absent from the joints of patients with sexually acquired reactive arthritis
124. A search for Chlamydia trachomatis in synovial fluids from patients with reactive arthritis using the polymerase chain reaction and antigen detection methods
125. Application of the polymerase chain reaction and immunofluorescence techniques to the detection of bacteria in Yersinia-triggered reactive arthritis
126. Yersinia-triggered reactive arthritis. Use of polymerase chain reaction and immunocytochemical staining in the detection of bacterial components from synovial specimens
127. Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction
128. Chlamydial rRNA in the joints of patients with Chlamydia-induced arthritis and undifferentiated arthritis
129. Molecular evidence for the presence of chlamydia in the synovium of patients with Reiter's syndrome
130. Recurrent arthritis in Reiter's syndrome: a function of inapparent chlamydial infection of the synovium?
131. Synovial inflammatory response to bacterial endotoxin
132. Arthritis in rabbits induced by killed Neisseria gonorrhoeae and gonococcal lipopolysaccharide
133. Proinflammatory microbial products as etiologic agents of inflammatory arthritis
134. Chronic arthritis induced in rats by cell wall fragments of Eubacterium species from the human intestinal flora
135. Lipopolysaccharides: Structural principles and biologic activities
136. The genus-specific antigen of Chlamydia: Resemblance to the lipopolysaccharide of enteric bacteria
137. Optimization of detection of bacterial endotoxin in plasma with the Limulus test
138. Detection of bacterial endotoxins: Another step forward
139. Arthritis in rats after systemic injection of streptococcal cells or cell walls
140. Antibodies to peptidoglycan in patients with spondylarthritis: a clue to disease aetiology?
141. High levels of antipeptidoglycan antibodies in psoriatic and other seronegative arthritides
142. Measurement of bacterial cell wall in tissues by solid-phase radioimmunoassay: correlation of distribution and persistence with experimental arthritis in rats.
143. Sensitive mass spectrometric procedure for the detection of bacterial cell wall components in rheumatoid joints
144. Antigenic bacterial polysaccharide in Rheumatoid joint effusions
145. Speculations on the functions of the major heat shock and glucose-regulated proteins
146. Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein
147. Induction of Salmonella stress proteins upon infection of macrophages
148. Heat shock proteins and arthritis
149. A role for heat shock proteins in inflammation?
150. In vitro responses to a 65-kilodalton mycobacterial protein by synovial T cells from inflammatory arthritis patients.
151. Immunoblot analysis of reactivity to chlamydial 57kD heat shock protein in Reiters syndrome
152. Phlogistic properties of bacterial debris
153. The Course of Reiter's Syndrome
154. Reactive Arthritis
155. REVIEW OF UK DATA ON THE RHEUMATIC DISEASES-10 REITER'S SYNDROME AND REACTIVE ARTHRITIS
156. The chronicity of symptoms and disability in Reiter's syndrome
157. Ten-year follow up study of patients with yersinia arthritis
158. Yersinia enterocolitica arthritis in southern Sweden: a four-year follow-up study
159. Natural history of arthritis following venereal infection
160. Occurrence of different ensuing triggering infections preceeding reactive arthritis: a follow up study
161. Reiter's disease—Report of a case successfully treated
162. Zur Behandlung der Reiterschen Krankheit (Ruhrrheumatismus)
163. Reiter's disease
164. Ueber eine bisher unerkannte Spirochäteninfektion (Spirochaetosis arthritica)
165. The in vivo action of aureomycin on pleuropneumonia-like organisms associated with various rheumatic diseases
166. Treatment of Reiter's syndrome by gold salts
167. Reiter's Disease
168. Reiter's Syndrome
169. Reiter's syndrome and focal infection.
170. Arthritis in the Mediterranean Theater of Operations
171. An "Experimental" Epidemic of Reiter's Syndrome
172. Value of treatment in Reiter's Disease
173. Arthritis in venereal disease with particular reference to aetiology
174. A prospective study of Reiter's Syndrome. An interim report on the first 82 cases
175. Therapeutics of non-gonococcal urethritis
176. Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study
177. Childhood myocarditis associated with Chlamydia trachomatis infection
178. Chlamydia trachomatis endocarditis
179. Isolation of Chlamydia trachomatis from the liver of a patient with prolonged fever
180. Meningoencephalitis associated with Chlamydia trachomatis infection
181. Chlamydia trachomatis as possible cause of peritonitis and perihepatitis in young women.
182. Ultrahistopathology of balanitis circinata
183. Keratoderma blennorrhagica
184. KERATOSIS BLENNORRHAGICA
185. Salmonella typhimurium enteritis and erythema nodosum
186. Comparison of erythromycin stearate and oxytetracycline in the treatment of non-gonococcal urethritis
187. Recognition and management of genital chlamydial infection
188. Recognition and treatment of chlamydial infections
189. A clinical and roentgenological follow-up study of patients with uroarthritis or pelvospondylitis
190. Long-term antibiotic treatment in reactive arthritis
191. Minocycline in the treatment of patients with Reiter's syndrome
192. Chlamydial infection and arthritis
193. Tetracyclines inhibit human synovial collagenase in vivo and in vitro
194. Should tetracyclines be used in arthritis?
195. The anticollagenolytic potential of lymecycline in the long-term treatment of reactive arthritis
196. Should we treat postvenereal Reiter's syndrome by antibiotics?
197. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis
198. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population
199. Treatment of resistant rheumatoid arthritis with minocycline: an open study
200. The cure and the controversy; Thomas Browns unorthodox fight against arthritis
201. HLA-linked disease susceptibility and reactive arthritis
202. HLA-B27 subtypes in the spondarthropathies
203. HLA-B27 subtypes: Implications for the spondyloarthropathies
204. Structure of the human class I histocompatibility antigen, HLA-A2
205. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation
206. Identification of self-peptides bound to purified HLA-B27
207. Peptide selection by MHC class I molecules
208. Role of class I molecules of the major histocompatability complex in cytotoxic T-cell function in health and disease
209. CD8+ T lymphocytes in intracellular microbial infections
210. MHC restriction of synovial fluid lymphocyte responses to the triggering organism in reactive arthritis. Absence of a class I-restricted response
211. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis
212. “Superantigens” may shed light on immune puzzle
213. Microbial “Superantigens.”
214. The Vβ-specific superantigen staphylococcal Endotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice
215. Crosses of two independently derived transgenic mice demonstrate functional complementation of the genes encoding heavy (HLA-B27) and light (β2-microglobulin) chains of HLA Class I antigens
216. Role of enterobacteria and HLA-B27 in spondyloarthropathies: Studies with transgenic mice
217. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2-m: an animal model of HLA-B27-associated human disorders
218. Susceptibility to HLA-B27-associated inflammatory disease in rats resides in bone marrow-derived cells
219. Passive transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow cells
220. Effect of the germfree state on the inflammatory disease of HLA-B27 transgenic rats: A split result
221. Molecular mimicry in the pathogenesis of rheumatic diseases
222. Autoanti-bodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease
223. A survey of isolates of Klebsiella pneumoniae which cross-react with HLA B27-associated cell surface structure on the lymphocytes of patients with ankylosing spondylitis
224. Antibody activity in ankylosing spondylitis sera to two sites on HLA B27.1 at the MHC groove region (within sequence 65–85), and to a Klebsiella pneumoniae nitrogenase reductase peptide (within sequence 181–199)
225. Ye-1, a monoclonal antibody that cross-reacts with HLA-B27 lymphoblastoid cell lines and an arthritis causing bacteria
226. Identification of HLA-B27M1 and -M2 cross reactive antigens in Klebsiella. Shigella and Yersinia
227. Anti HLA-B27 antibodies in sera from patients with Gram-negative bacterial infections
228. Antibodies to Enterobacteriaceae in ankylosing spondylitis
229. Epitope mapping of an HLA-B27 monoclonal antibody that also reacts with a 35-kD bacterial outer-mambrane protein
230. Lack of correlation between HLA-B27 like antigenic epitopes on Shigella flexneri and the occurrence of reactive arthritis
231. Klebsiella pneumoniae and HLA B27-associated diseases of Reiter's syndrome and ankylosing spondylitis
232. Studies of humoral and cell-mediated immunity to peptides shared by HLA-27.1 and Klebsiella pneumoniae nitrogenase in ankylosing spondylitis
233. Identification of a 2-Md plasmid from Shigella flexneri associated with reactive arthritis
234. Lack of DNA homology between arthritis triggering bacteria and plasmid of Yersinia enterocolitica or Chlamydia trachomatis [letter]
235. HLA-B27/microbial mimicry: an in vivo analysis
236. Molecular mimicry in the pathogenesis of spondyloarthropathies. A critical appraisal of cross-reactivity between microbial antigens and HLA-B27
237. Do synovial fluid cells indicate the cause of reactive arthritis?
238. Synovial T lymphocyte recognition of organisms that trigger reactive arthritis
239. Proliferative responses of mononuclear cells in Lyme disease. Reactivity to Borrelia burgdorferi antigens is greater in joint fluid than in blood
240. Lymphocytes from the site of disease but not blood lymphocytes indicate the cause of arthritis
241. Depressed lymphocyte transformation by yersinia and Escherichia coli in yersinia arthritis
242. Cell-mediated immune responses of synovial mononuclear cells in Reiter's syndrome against Ureaplasma and Chlamydial antigens
243. Human lymphocyte response to selected infectious agents in Reiter's syndrome and ankylosing spondylitis
244. High antigen reactivity in mononuclear cells from sites of chronic inflammation
245. Proliferative response of synovial fluid and peripheral blood mononuclear cells to arthritogenic and non-arthritogenic microbial antigens and to the 65-kDa mycobacterial heat-shock protein
246. The distribution of dendritic cells in the synovial fluid of patients with arthritis
247. The distribution and functional properties of dendritic cells in patients with seronegative arthritis
248. Antigen-presenting cells but not lymphocytes in the joint may indicate the cause of reactive arthritis
249. Peripheral blood and synovial fluid T-cells differ in their responses to alloantigens and recall antigens presented by dendritic cells
250. Human immunodeficiency virus infection and the rheumatologist
251. The severe combined immunodeficiency (SCID) mouse. A laboratory model for the analysis of Lyme arthritis and carditis
252. Polymorphonuclear cell motility, ankylosing spondylitis, and HLA B27
253. Neutrophil function and HLA-B27
254. Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease
255. HLA-B27 expression modulates gram-negative bacterial invasion into transfected L cells
256. A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium
257. Intercellular adhesion molecules in normal synovium